103 related articles for article (PubMed ID: 8199034)
1. Clinical and haematological improvement induced by etidronate in a patient with idiopathic myelofibrosis and osteosclerosis.
Sivera P; Cesano L; Guerrasio A; Camaschella C; Mazza U
Br J Haematol; 1994 Feb; 86(2):397-8. PubMed ID: 8199034
[TBL] [Abstract][Full Text] [Related]
2. Clodronate in myelofibrosis: a case report.
Froom P; Elmalah I; Braester A; Aghai E; Quitt M
Am J Med Sci; 2002 Feb; 323(2):115-6. PubMed ID: 11863080
[TBL] [Abstract][Full Text] [Related]
3. Ultrastructure of bone marrow tissue in so-called primary (idiopathic) myelofibrosis-osteomyelosclerosis (agnogenic myeloid metaplasia). II. The myeloid stroma (hematopoietic microenvironment).
Thiele J; Schmidt J; Sander C; Fischer R
J Submicrosc Cytol Pathol; 1991 Jan; 23(1):109-21. PubMed ID: 2036622
[TBL] [Abstract][Full Text] [Related]
4. Agnogenic myeloid metaplasia with pulmonary hematopoiesis.
Boula A; Mantadakis E; Xilouri I; Foudoulakis A; Samonis G
Hematology; 2005 Dec; 10(6):501-3. PubMed ID: 16321815
[TBL] [Abstract][Full Text] [Related]
5. Syndrome of myelofibrosis and osteosclerosis: a series of case reports and review of the literature.
Diamond T; Smith A; Schnier R; Manoharan A
Bone; 2002 Mar; 30(3):498-501. PubMed ID: 11882464
[TBL] [Abstract][Full Text] [Related]
6. Aleukemic Myelosis: Chronic Nonleukemic Myelosis, Agnogenic Myeloid Metaplasia, Osteosclerosis, Leuko-Erythroblastic Anemia, and Synonymous Designations.
Heller EL; Lewisohn MG; Palin WE
Am J Pathol; 1947 May; 23(3):327-65. PubMed ID: 19970934
[No Abstract] [Full Text] [Related]
7. Histomorphometric analysis of sclerotic bone from idiopathic myeloid metaplasia (nine cases).
Coindre JM; Reiffers J; Goussot JF; De Mascarel A; Broustet A
J Pathol; 1984 Nov; 144(3):163-9. PubMed ID: 6502295
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the androgen response of 23 patients with agnogenic myeloid metaplasia: the value of chromosomal studies in predicting response and survival.
Besa EC; Nowell PC; Geller NL; Gardner FH
Cancer; 1982 Jan; 49(2):308-13. PubMed ID: 7053830
[TBL] [Abstract][Full Text] [Related]
9. Progressive myelofibrosis in agnogenic myeloid metaplasia.
Lohmann TP; Beckman EN
Arch Pathol Lab Med; 1983 Nov; 107(11):593-4. PubMed ID: 6688716
[TBL] [Abstract][Full Text] [Related]
10. Plasma matrix metalloproteinase and tissue inhibitor of metalloproteinase in patients with agnogenic myeloid metaplasia or idiopathic primary myelofibrosis.
Wang JC; Novetsky A; Chen C; Novetsky AD
Br J Haematol; 2002 Dec; 119(3):709-12. PubMed ID: 12437648
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow histopathology and biological markers as specific clues to the differential diagnosis of essential thrombocythemia, polycythemia vera and prefibrotic or fibrotic agnogenic myeloid metaplasia.
Michiels JJ
Hematol J; 2004; 5(2):93-102. PubMed ID: 15048058
[TBL] [Abstract][Full Text] [Related]
12. Treatment of agnogenic myeloid metaplasia with danazol: a report of four cases.
Lévy V; Bourgarit A; Delmer A; Legrand O; Baudard M; Rio B; Zittoun R
Am J Hematol; 1996 Dec; 53(4):239-41. PubMed ID: 8948661
[TBL] [Abstract][Full Text] [Related]
13. Acute megakaryoblastic leukemia (acute "malignant" myelofibrosis): an unusual cause of osteosclerosis.
Karasick S; Karasick D; Schilling J
Skeletal Radiol; 1982; 9(1):45-6. PubMed ID: 6961530
[TBL] [Abstract][Full Text] [Related]
14. Influence of disodium etidronate on Paget's disease of bone.
Muir HG; Schabort I; Hough FS
S Afr Med J; 1987 Oct; 72(7):470-2. PubMed ID: 3116683
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow angiogenesis and its clinical correlates in myelofibrosis with myeloid metaplasia.
Arora B; Ho CL; Hoyer JD; Mesa RA; Tefferi A
Haematologica; 2004 Dec; 89(12):1454-8. PubMed ID: 15590395
[TBL] [Abstract][Full Text] [Related]
16. Plasma cell dyscrasia with marrow fibrosis. A reversible syndrome mimicking agnogenic myeloid metaplasia.
Meerkin D; Ashkenazi Y; Gottschalk-Sabag S; Hershko C
Cancer; 1994 Feb; 73(3):625-8. PubMed ID: 8299083
[TBL] [Abstract][Full Text] [Related]
17. Childhood myelofibrosis and osteosclerosis without myeloid metaplasia.
Tebbi K; Zarkowsky HS; Siegel BA; McAlister WH
J Pediatr; 1974 Jun; 84(6):860-2. PubMed ID: 4826622
[No Abstract] [Full Text] [Related]
18. Primary (essential) thrombocythemia versus initial (hyperplastic) stages of agnogenic myeloid metaplasia with thrombocytosis--a critical evaluation of clinical and histomorphological data.
Thiele J; Zankovich R; Steinberg T; Kremer B; Fischer R; Diehl V
Acta Haematol; 1989; 81(4):192-202. PubMed ID: 2474228
[TBL] [Abstract][Full Text] [Related]
19. Clonal analysis of agnogenic myeloid metaplasia.
Kreipe H; Jaquet K; Felgner J; Parwaresch MR
Leuk Lymphoma; 1992 Dec; 8(6):459-64. PubMed ID: 1363649
[TBL] [Abstract][Full Text] [Related]
20. [Indications for cytostatic treatment of patients with osteomyelosclerosis of osteomyelofibrosis].
Engelmann C; Schulz K; Nowotny P; Konrad H
Dtsch Gesundheitsw; 1972 Dec; 27(50):2375-80. PubMed ID: 4651200
[No Abstract] [Full Text] [Related]
[Next] [New Search]
